Boston Scientific Corporation vs Marqeta Inc — how do they compare? Boston Scientific Corporation trades at $51.07 (market cap $74.19B), while Marqeta Inc trades at $15.52 (market cap $1.62B). The key difference: Boston Scientific Corporation is far larger — about 45.8× Marqeta Inc's market cap. Which is the better fit depends on your goals.
| BSX | MQ | |
|---|---|---|
Market Cap | $74.19B | $1.62B |
Sector | Health | Technology |
52-Week High | $108.14 | $26.00 |
52-Week Low | $42.63 | $15.04 |
Enterprise Value | $86.27B | $935.36M |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →